These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 23143962)

  • 21. Interacting effects of the dopamine transporter gene and psychosocial adversity on attention-deficit/hyperactivity disorder symptoms among 15-year-olds from a high-risk community sample.
    Laucht M; Skowronek MH; Becker K; Schmidt MH; Esser G; Schulze TG; Rietschel M
    Arch Gen Psychiatry; 2007 May; 64(5):585-90. PubMed ID: 17485610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopaminergic haplotype as a predictor of spatial inattention in children with attention-deficit/hyperactivity disorder.
    Bellgrove MA; Johnson KA; Barry E; Mulligan A; Hawi Z; Gill M; Robertson I; Chambers CD
    Arch Gen Psychiatry; 2009 Oct; 66(10):1135-42. PubMed ID: 19805704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The dopamine transporter gene and the impulsivity phenotype in attention deficit hyperactivity disorder: a case-control association study in a Korean sample.
    Kim JW; Kim BN; Cho SC
    J Psychiatr Res; 2006 Dec; 40(8):730-7. PubMed ID: 16368111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular genetics of attention-deficit/hyperactivity disorder.
    Faraone SV; Perlis RH; Doyle AE; Smoller JW; Goralnick JJ; Holmgren MA; Sklar P
    Biol Psychiatry; 2005 Jun; 57(11):1313-23. PubMed ID: 15950004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haplotype relative risk study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD): association of the high-enzyme activity Val allele with ADHD impulsive-hyperactive phenotype.
    Eisenberg J; Mei-Tal G; Steinberg A; Tartakovsky E; Zohar A; Gritsenko I; Nemanov L; Ebstein RP
    Am J Med Genet; 1999 Oct; 88(5):497-502. PubMed ID: 10490706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High sibling correlation on methylphenidate response but no association with DAT1-10R homozygosity in Dutch sibpairs with ADHD.
    van der Meulen EM; Bakker SC; Pauls DL; Oteman N; Kruitwagen CL; Pearson PL; Sinke RJ; Buitelaar JK
    J Child Psychol Psychiatry; 2005 Oct; 46(10):1074-80. PubMed ID: 16178931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential associations of dopamine-related polymorphisms with discrete components of reaction time variability: relevance for attention deficit/hyperactivity disorder.
    Grant P; Kuepper Y; Wielpuetz C; Hennig J
    Neuropsychobiology; 2014; 69(4):220-6. PubMed ID: 24942140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is the alpha-2A adrenergic receptor gene (ADRA2A) associated with attention-deficit/hyperactivity disorder?
    Roman T; Schmitz M; Polanczyk GV; Eizirik M; Rohde LA; Hutz MH
    Am J Med Genet B Neuropsychiatr Genet; 2003 Jul; 120B(1):116-20. PubMed ID: 12815749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No association between MspI allele of the ADRA2A polymorphism and ADHD: meta-analysis of family-based studies.
    Shiffrin ND; Gruber J; Glatt SJ; Faraone SV
    Psychiatr Genet; 2013 Aug; 23(4):174-5. PubMed ID: 23751900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The genetics of attention deficit hyperactivity disorder.
    Thapar A; O'Donovan M; Owen MJ
    Hum Mol Genet; 2005 Oct; 14 Spec No. 2():R275-82. PubMed ID: 16244326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine receptor DRD4 gene and stressful life events in persistent attention deficit hyperactivity disorder.
    Sánchez-Mora C; Richarte V; Garcia-Martínez I; Pagerols M; Corrales M; Bosch R; Vidal R; Viladevall L; Casas M; Cormand B; Ramos-Quiroga JA; Ribasés M
    Am J Med Genet B Neuropsychiatr Genet; 2015 Sep; 168(6):480-491. PubMed ID: 26174753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Should we keep on? Looking into pharmacogenomics of ADHD in adulthood from a different perspective.
    Rovaris DL; Mota NR; da Silva BS; Girardi P; Victor MM; Grevet EH; Bau CH; Contini V
    Pharmacogenomics; 2014 Jul; 15(10):1365-81. PubMed ID: 25155937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ADHD-associated dopamine transporter, latrophilin and neurofibromin share a dopamine-related locomotor signature in Drosophila.
    van der Voet M; Harich B; Franke B; Schenck A
    Mol Psychiatry; 2016 Apr; 21(4):565-73. PubMed ID: 25962619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attention deficit hyperactivity disorder pharmacogenetics: the dopamine transporter and D4 receptor.
    McGough JJ
    Pharmacogenomics; 2012 Mar; 13(4):365-8. PubMed ID: 22379991
    [No Abstract]   [Full Text] [Related]  

  • 35. Biochemical and genetic analyses of childhood attention deficit/hyperactivity disorder.
    Caylak E
    Am J Med Genet B Neuropsychiatr Genet; 2012 Sep; 159B(6):613-27. PubMed ID: 22825876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction between lead and noradrenergic genotypes affects neurocognitive functions in attention-deficit/hyperactivity disorder: a case control study.
    Choi JW; Jung AH; Nam S; Kim KM; Kim JW; Kim SY; Kim BN; Kim JW
    BMC Psychiatry; 2020 Aug; 20(1):407. PubMed ID: 32791971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissociation of impulsivity and aggression in mice deficient for the ADHD risk gene Adgrl3: Evidence for dopamine transporter dysregulation.
    Mortimer N; Ganster T; O'Leary A; Popp S; Freudenberg F; Reif A; Soler Artigas M; Ribasés M; Ramos-Quiroga JA; Lesch KP; Rivero O
    Neuropharmacology; 2019 Sep; 156():107557. PubMed ID: 30849401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The genetics of attention deficit hyperactivity disorder.
    Waldman ID; Gizer IR
    Clin Psychol Rev; 2006 Aug; 26(4):396-432. PubMed ID: 16513236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fitting the pieces together: current research on the genetic basis of attention-deficit/hyperactivity disorder (ADHD).
    Stergiakouli E; Thapar A
    Neuropsychiatr Dis Treat; 2010 Sep; 6():551-60. PubMed ID: 20856918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unravelling the complexity of attention-deficit hyperactivity disorder: a behavioural genomic approach.
    Asherson P; Kuntsi J; Taylor E
    Br J Psychiatry; 2005 Aug; 187():103-5. PubMed ID: 16055819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.